Login / Signup

Real-World Outcomes Following First-Line Treatment in Patients with Advanced Ovarian Cancer with Multiple Risk Factors for Disease Progression who Received Maintenance Therapy or Active Surveillance.

Dana ChaseJessica PerhanidisDivya GuptaLinda KalilaniAmanda GolembeskyAntonio González-Martín
Published in: Oncology and therapy (2023)
Regardless of RF number, MT was associated with longer TTNT in real-world patients with AOC.
Keyphrases
  • mesenchymal stem cells
  • bone marrow
  • smoking cessation
  • cell therapy